Abstract:Abstract Proliferating cell nuclear antigen (PCNA), also called cyclin, is an intranuclear polypeptide whose synthesis reaches its maximum during the S-phase of the cell cycle. PCNA is expressed in several kinds of proliferating cells, one of which is the mitogen-stimulated human peripheral blood lymphocyte. PCNA expression increases from the late G1 phase through the S-phase of the cell cycle. This study is focused on the regulation of PCNA expression during the G1 phase of human T lymphocytes and on the relationship between PCNA expression and the rate of T cell proliferation. Special use is made of human autoantibodies to PCNA and the development of flow cytometry to label this intranuclear polypeptide. Unstimulated purified human peripheral blood T cells were PCNA negative. T cells treated with monoclonal antibody (64.1) to the CD3 complex expressed receptors for IL 2 but did not express PCNA until exogenous IL 2 was added to the culture. PCNA expression as well as the entry of the cells into S-phase could be inhibited by IL 2 receptor antibodies. Transferrin receptors were expressed only in T cells that were stimulated with both 64.1 and exogenous IL 2. Transferrin receptors were detectable before the cells expressed PCNA. Thus, the onset of PCNA expression is a phase in cell proliferation that follows transferrin receptor expression but preceded DNA synthesis. Drugs like dexamethasone and cyclosporin, which affect the early part of G1, inhibited PCNA expression; whereas cytarabine (ara-C) and hydroxyurea, which affect the S-phase and prevent DNA synthesis, did not block PCNA expression. There was a close correlation between the number of PCNA-positive cells and the number of S-phase cells in unperturbed T cell cultures. The highest level of PCNA expression was seen in cells that were in the first cycle after stimulation. The results show that PCNA expression is regulated by a signal after IL 2 binding and that PCNA labeling is a precise indicator for human T cells that are committed to DNA synthesis. Comparing these results with previous observations on the expression of some other activation-associated antigens, we suggest that the onset of PCNA expression represents a discrete step in T cell activation.

Proliferating cell nuclear antigen (PCNA): ringmaster of the genome

Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation

Proliferating cell nuclear antigen (PCNA): a dancer with many partners

PCNA: structure, functions and interactions

PCNA on the crossroad of cancer

PCNA, the Maestro of the Replication Fork

Protein–PCNA interactions: a DNA-scanning mechanism?

Role of PCNA in DNA repair

PCNA: a silent housekeeper or a potential therapeutic target?

Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.

Maneuvers on PCNA Rings during DNA Replication and Repair

Post-translational modifications of proliferating cell nuclear antigen: A key signal integrator for DNA damage response (Review).

Effects of PCNA Stability on the Formation of Mutations

Screening and Sequencing of the Human Proliferating Cell Nuclear Antigen (pcna) Genomic Gene and the Analysis of Its Promoter

Phosphorylation of Proliferating Cell Nuclear Antigen Promotes Cancer Progression by Activating the ATM/Akt/GSK3β/Snail Signaling Pathway.

Active Cis-Elements of PCNA Promoter in HeLa, HepG2, L-02 and MCF-7 Cell Lines.

Control of Genome Integrity by RFC Complexes; Conductors of PCNA Loading onto and Unloading from Chromatin during DNA Replication

The Functions of PCNA in Tumor Stemness and Invasion

CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication

Post-Translational Modifications of PCNA in Control of DNA Synthesis and DNA Damage Tolerance-the Implications in Carcinogenesis

Efficient PCNA complex formation is dependent upon both transcription coupled repair and genome overall repair